论文部分内容阅读
美国得克萨斯圣安东尼奥消息:美国、加拿大和欧洲的研究组在美国糖尿病协会会议上报告,虽然推广胰岛素泵的应用并增加了经验,但是低血糖、酮中毒和感染使其应用受到阻碍。研究人员报告,在一大组100—200名病人中,连续皮下输注胰岛素(CSⅡ)的病人患严重低血糖的高达20％,输注部位感染的达15％,还有10％患酮中毒。虽然专家们强调说,由于适当的选择和训练病人以及泵的正确操作,CSⅡ在糖尿病处理得到明显的进展,但是有些人对于报告的有害
SAN ANTONIO, TEXAS, TEXT: Research groups from the United States, Canada and Europe reported at the American Diabetes Association meeting that although the use of insulin pumps has been promoted and gained more experience, hypoglycemia, ketosis and infections have hindered their use. The researchers reported that in a large group of 100-200 patients, patients receiving continuous subcutaneous insulin infusion (CSII) had up to 20% of severe hypoglycaemia, 15% of infections at the infusion site, and 10% had ketosis . Although the experts emphasize that CS II has made significant progress in the management of diabetes due to the proper choice and training of patients and the correct operation of the pump, some people report harmful